Atlas Trials

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

Clinical trial NCT07261592 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07261592
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bladder CancerHistone Deacetylase InhibitorEntinostatChemotherapy
Start date
2025-12-01
Primary completion
2028-09-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.